ACTIVE SUBSTANCE / INN

LEVONORDEFRIN

Brand name(s): ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN, RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN, SCANDONEST L, ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN, POLOCAINE W/ LEVONORDEFRIN, CARBOCAINE W/ NEO-COBEFRIN, MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN
FDA LISTED
DISCONTINUED
ANDA088388
ANDA084850
ACTIVE SUBSTANCE
Levonordefrin
REGULATORS
FDA
SPONSORS / MAH
EASTMAN KODAK, DENTSPLY PHARM, BELMORA LLC
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRINNDA008592EASTMAN KODAKDiscontinued
ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRINANDA085010SOLVAYDiscontinued
MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRINANDA084850BELMORA LLCDiscontinued
SCANDONEST LANDA088388DEPROCODiscontinued
POLOCAINE W/ LEVONORDEFRINANDA089517DENTSPLY PHARMDiscontinued
ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRINANDA084697SEPTODONTDiscontinued
CARBOCAINE W/ NEO-COBEFRINNDA012125EASTMAN KODAKDiscontinued

FULL INTELLIGENCE ON LEVONORDEFRIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →